Radiopharm Theranostics Limited (AU:RAD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Radiopharm Theranostics Limited has announced the issuance of 149,925,040 unquoted equity securities, specifically options expiring on February 24, 2025, with an exercise price of $0.05. The move, dated August 23, 2024, is part of a transaction previously communicated to the market and will not result in the options being quoted on the ASX.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.